KOL about using RNA-seq in clinical cancer diagnostics

Interview with Thoas Fioretos, Professor in Clinical Genetics, Lund University in Sweden. In the interview questions about using RNA seq in clinical diagnostics and meeting future needs in precision diagnostics - such as the new IVD regulation are discussed.  
Some of the topics: 

• Benefits of using Next Generation Sequencing 

• Added value with using whole transcriptomic RNA sequencing, such as novel and known gene fusions and gene expression-based classification. 

• Trends and future needs in clinical diagnostics